Cyanotech Corporation (CYAN) Financial Statements (2024 and earlier)

Company Profile

Business Address 73-4460 QUEEN KAAHUMANU HWY
KAILUA KONA, HI 96740
State of Incorp. NV
Fiscal Year End March 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6489745133797372,589
Cash and cash equivalents6489745133797372,589
Receivables1,7941,3312,1562,1183,2013,664
Inventory, net of allowances, customer advances and progress billings10,50610,70711,57412,08810,6999,466
Inventory10,50610,70711,57412,08810,6999,466
Other undisclosed current assets378484284356386545
Total current assets:13,32613,49614,52714,94115,02316,264
Noncurrent Assets
Operating lease, right-of-use asset4,6564,7763,4633,5733,6823,787
Property, plant and equipment11,06511,36611,69311,74711,91611,885
Other noncurrent assets8590899295109
Total noncurrent assets:15,80616,23215,24515,41215,69315,781
TOTAL ASSETS:29,13229,72829,77230,35330,71632,045
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,5422,1222,0193,4934,2644,865
Employee-related liabilities8711,0001,091
Accounts payable1,7211,0211,0311,5441,9272,362
Accrued liabilities8211,1019881,0781,3371,412
Deferred revenue7789979279164
Debt5,8335,4092,311   
Other undisclosed current liabilities4944832431,000(270)(208)
Total current liabilities:8,9468,1034,6704,5854,0734,821
Noncurrent Liabilities
Long-term debt and lease obligation1,0001,0004,1667,4777,5987,722
Long-term debt, excluding current maturities1,0001,0004,1664,2124,2734,336
Liabilities, other than long-term debt4,1464,2783,20351115
Other liabilities  3 51115
Operating lease, liability4,1464,2753,2033,2653,3253,386
Total noncurrent liabilities:5,1465,2787,3697,4827,6097,737
Total liabilities:14,09213,38112,03912,06711,68212,558
Equity
Equity, attributable to parent15,04016,34717,73318,28619,03419,487
Common stock126125125125124124
Additional paid in capital33,91733,85633,81233,76733,57633,557
Accumulated deficit(19,003)(17,634)(16,204)(15,606)(14,666)(14,194)
Total equity:15,04016,34717,73318,28619,03419,487
TOTAL LIABILITIES AND EQUITY:29,13229,72829,77230,35330,71632,045

Income Statement (P&L) ($ in thousands)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
Revenues5,146(4,664)5,8915,1796,71613,061
Cost of revenue
(Cost of Goods and Services Sold)
(3,614)1,251(4,127)(3,389)(4,398)(7,842)
Gross profit:1,532(3,413)1,7641,7902,3185,219
Operating expenses(2,741)(1,717)(2,168)(2,627)(2,743)(2,754)
Operating income (loss):(1,209)(5,130)(404)(837)(425)2,465
Interest and debt expense(160)(190)(186)(103)(44)(1,407)
Other undisclosed loss from continuing operations before equity method investments, income taxes  (502)    
Income (loss) from continuing operations before equity method investments, income taxes:(1,369)(5,822)(590)(940)(469)1,058
Other undisclosed income from continuing operations before income taxes  502    
Income (loss) from continuing operations before income taxes:(1,369)(5,320)(590)(940)(469)1,058
Income tax expense (benefit) 3(8) (3)(25)
Income (loss) from continuing operations:(1,369)(5,317)(598)(940)(472)1,033
Income (loss) before gain (loss) on sale of properties:(940)(472)1,033
Net income (loss) available to common stockholders, diluted:(1,369)(5,317)(598)(940)(472)1,033

Comprehensive Income ($ in thousands)

9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
Net income (loss):(1,369)(5,317)(598)(940)(472)1,033
Comprehensive income (loss), net of tax, attributable to parent:(1,369)(5,317)(598)(940)(472)1,033

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: